Valproic acid, sodium butyrate, and Vorinostat (SAHA) are examples of HDAC inhibitors that are currently used to target depression, schizophrenia, BD, PTSD and are being preclinically explored for ASD (120). The gene discussed is HDAC9; the disease is major depressive disorder.